These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 21183990

  • 1. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs.
    Gu J, Su S, Li Y, He Q, Shi J.
    Chem Commun (Camb); 2011 Feb 21; 47(7):2101-3. PubMed ID: 21183990
    [Abstract] [Full Text] [Related]

  • 2. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.
    J Control Release; 2008 May 08; 127(3):208-18. PubMed ID: 18336946
    [Abstract] [Full Text] [Related]

  • 3. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J, Chen XG, Li YY, Liu CS.
    Nanomedicine; 2007 Dec 08; 3(4):258-65. PubMed ID: 17962086
    [Abstract] [Full Text] [Related]

  • 4. Facile synthesis of hydrophilic multi-colour and upconversion photoluminescent mesoporous carbon nanoparticles for bioapplications.
    Kong Q, Zhang L, Liu J, Wu M, Chen Y, Feng J, Shi J.
    Chem Commun (Camb); 2014 Dec 25; 50(99):15772-5. PubMed ID: 25371274
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR, Hua SC, Yang YL, Fang JY.
    Acta Pharmacol Sin; 2008 Sep 25; 29(9):1094-102. PubMed ID: 18718178
    [Abstract] [Full Text] [Related]

  • 6. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
    Ling G, Zhang P, Zhang W, Sun J, Meng X, Qin Y, Deng Y, He Z.
    J Control Release; 2010 Dec 01; 148(2):241-8. PubMed ID: 20727928
    [Abstract] [Full Text] [Related]

  • 7. [Synthesis of polyrotaxane-camptothecin conjugates and evaluation of its anti-tumor effect].
    Lai CL, Lai L, Zhao JB, Chen JH.
    Yao Xue Xue Bao; 2010 Jul 01; 45(7):920-5. PubMed ID: 20931793
    [Abstract] [Full Text] [Related]

  • 8. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
    Koo OM, Rubinstein I, Onyuksel H.
    Nanomedicine; 2005 Mar 01; 1(1):77-84. PubMed ID: 17292061
    [Abstract] [Full Text] [Related]

  • 9. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
    Zhao Z, He M, Yin L, Bao J, Shi L, Wang B, Tang C, Yin C.
    Biomacromolecules; 2009 Mar 09; 10(3):565-72. PubMed ID: 19175304
    [Abstract] [Full Text] [Related]

  • 10. Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin.
    Davis ME.
    Adv Drug Deliv Rev; 2009 Nov 12; 61(13):1189-92. PubMed ID: 19682514
    [Abstract] [Full Text] [Related]

  • 11. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y.
    J Control Release; 2010 Jan 04; 141(1):22-9. PubMed ID: 19735683
    [Abstract] [Full Text] [Related]

  • 12. The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells.
    Jin C, Wu H, Liu J, Bai L, Guo G.
    J Clin Pharm Ther; 2007 Feb 04; 32(1):41-7. PubMed ID: 17286788
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS, Song JY, Cho SH, Lee BS, Kim SY, Kim K, Jeon H, Kwon IC, Yuk SH.
    J Control Release; 2010 Dec 20; 148(3):344-50. PubMed ID: 20797418
    [Abstract] [Full Text] [Related]

  • 14. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 15. High-Capacity Drug Carriers from Common Polymer Amphiphiles.
    Zhou Z, Munyaradzi O, Xia X, Green D, Bong D.
    Biomacromolecules; 2016 Sep 12; 17(9):3060-6. PubMed ID: 27476544
    [Abstract] [Full Text] [Related]

  • 16. Effect of interleukins response to ECM-induced acquisition of drug resistance in MCF-7 cells.
    Ohbayashi M, Yasuda M, Kawakami I, Kohyama N, Kobayashi Y, Yamamoto T.
    Exp Oncol; 2008 Dec 12; 30(4):276-82. PubMed ID: 19112424
    [Abstract] [Full Text] [Related]

  • 17. Feedback-regulated paclitaxel delivery based on poly(N,N-dimethylaminoethyl methacrylate-co-2-hydroxyethyl methacrylate) nanoparticles.
    You JO, Auguste DT.
    Biomaterials; 2008 Apr 12; 29(12):1950-7. PubMed ID: 18255142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fatty acid based hyperbranched polymeric nanoparticles for hydrophobic drug delivery.
    Güç E, Gündüz G, Gündüz U.
    Drug Dev Ind Pharm; 2010 Oct 12; 36(10):1139-48. PubMed ID: 20370416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.